Clonal CD8+ T-cell expansion is associated with complete response to elranatamab in refractory multiple myeloma

Roman Krzysiek1, Samuel Bitoun2, Rakiba Belkhir2

  • 1Clinical Immunology Laboratory, Groupe Hospitalier Universitaire Paris Saclay, Hôpital Bicêtre, Assistance Publique-Hôpitaux de Paris, Le-Kremlin-Bicêtre, France; UMR 996 INSERM, Inflammation Microbiome and Immunosurveillance, Paris-Saclay University, Orsay.

Haematologica
|March 28, 2024
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos